Vitiligo: A Comprehensive Review of the Etiology, Pathogenesis and Therapeutic Approaches to a Complex Dermatological Disease of Cutaneous Depigmentation

Article Sidebar

PDF
Published: Aug 14, 2023
DOI: https://doi.org/10.47191/ijmscrs/v3-i8-33
Keywords:
Vitiligo, Cutaneous depigmentation, Melanocytes, Autoimmunity, Therapeutic treatment.

Main Article Content

Nataly Paola Rentería Vázquez
Hospital General Regional #1 Instituto Mexicano del Seguro Social, Santiago de Querétaro, Querétaro, México
Susana González Hernández
Hospital General Dr. Dario Fernandez Fierro. Instituto de Seguridad y Servicios Sociales de los Trabajadores del Estado. Ciudad de México, México.
Brisa Arlin Gómez Arteaga
Hospital Regional del Instituto de Seguridad y Servicios Sociales de los Trabajadores del Estado de León. León, Guanajuato.
Keren Vazquez Ballesteros
Escuela Superior de Medicina, Instituto Politécnico Nacional. México.
Irisdey Espinoza Urzua
Universidad Nacional Autónoma de Mexico, Ciudad de México, México

Abstract

Vitiligo, an enigmatic and complex skin disease, is notable for the appearance of depigmented patches that arise due to the selective and progressive loss of melanocytes, the cells responsible for melanin production. This autoimmune pathology affects individuals of both genders and has been the subject of historical interest due to its unusual clinical presentation and its impact on patients' quality of life. The etiology of vitiligo is multifactorial, involving a combination of genetic, environmental and autoimmune factors leading to melanocyte destruction.


Although diagnosis is usually based on visual examination of the skin lesions, additional tests may be required to rule out other conditions with similar features. Although a definitive cure has not yet been found, a variety of therapeutic approaches, including topical treatments, phototherapy, systemic therapy and surgical options, are available to attempt to repigment affected areas and improve patients' quality of life. Continued research and a deeper understanding of the pathogenesis of vitiligo are essential to address this disease more effectively and provide more successful therapeutic solutions.

Article Details

How to Cite
Nataly Paola Rentería Vázquez, Susana González Hernández, Brisa Arlin Gómez Arteaga, Keren Vazquez Ballesteros, & Irisdey Espinoza Urzua. (2023). Vitiligo: A Comprehensive Review of the Etiology, Pathogenesis and Therapeutic Approaches to a Complex Dermatological Disease of Cutaneous Depigmentation. International Journal of Medical Science and Clinical Research Studies, 3(8), 1619–1622. https://doi.org/10.47191/ijmscrs/v3-i8-33
Issue
Vol. 3 No. 8 (2023): Volume 03 Issue 08 August 2023
Section
Articles
Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

References

I. Iannella G, Greco A, Didona D, Didona B, Granata G, Manno A, Pasquariello B, Magliulo G. Vitiligo: pathogenesis, clinical variants and treatment approaches. Autoimmunity Reviews. 2016 04;15(4):335-343. https://doi.org/10.1016/j.autrev.2015.12.006

II. Xie, H. et al. Vitiligo: How do oxidative stress-induced autoantigens trigger autoimmunity? J Dermatol Sci. 2015; https://doi.org/10.1016/j.jdermsci.2015.09.003.

III. Speeckaert, R. et al. Vitiligo: An Update on Pathophysiology and Treatment Options. Am J Clin Dermatol. 2017; 18: 733-744. https://doi.org/10.1007/s40257-017-0298-5

IV. Rashighi, M. et al. Vitiligo pathogenesis and emerging treatments. Dermatol Clin. 2017; 35 (2): 257-265. https://doi.org/10.1016/j.det.2016.11.014

V. Mole, M. and Coringrato, M. Update on vitiligo. Dermatología Argentina. 2019; 25 (2): 50-57. Available: http://www.dermatolarg.org.ar/index.php/dermatolarg/article/viewArticle/1874

VI. Alikhan A, Felsten LM, Daly M, Petronic-Rosic V. Vitiligo: A comprehensive overview. Journal of the American Academy of Dermatology. 2011 09;65(3):473-491. https://doi.org/10.1016/j.jaad.2010.11.061

VII. Rodrigues, M. et al. New discoveries in the pathogenesis and classification of vitiligo. J Am Acad Dermatol. 2017; 77:1-13. http://dx.doi.org/10.1016/j.jaad.2016.10.048

VIII. Picardo M, Dell'Anna ML, Ezzedine K, Hamzavi I, Harris JE, Parsad D, Taieb A. Vitiligo. Nature Reviews DiseasePrimers. 2015 06 04;1(1). https://doi.org/10.1038/nrdp.2015.11.

IX. Boniface, K. et al. Vitiligo: Focus on Clinical Aspects, Immunopathogenesis, and Therapy. Clinic Rev Allerg Immunol. (2018); 54:52-67. https://doi.org/10.1007/s12016-017-8622-7

X. Goh B, Pandya AG. Presentations, Signs of Activity, and Differential Diagnosis of Vitiligo. Dermatologic Clinics. 2017 04;35(2):135-144. https://doi.org/10.1016/j.det.2016.11.004

XI. Dahir AM, Thomsen SF. Comorbidities in vitiligo: comprehensive review. International Journal of Dermatology. 2018 05 28;57(10):1157-1164. https://doi.org/10.1111/ijd.14055

XII. Blanca Lucina Campos-Cabrera, Juan Carlos Juárez-Echenique, Marimar Saez-de Ocariz, Luz Orozco-Covarrubias. Association between vitiligo and ophthalmologic alterations. Dermatol Rev Mex. 2019; 63 (3): 268-277. Available at:https://www.medigraphic.com/pdfs/derrevmex/rmd-2019/rmd193d.pdf

XIII. Elbuluk N, Ezzedine K. Quality of Life, Burden of Disease, Co-morbidities, and Systemic Effects in Vitiligo Patients. Dermatologic Clinics. 2017 04;35(2):117-128. https://doi.org/10.1016/j.det.2016.11.002

XIV. Passeron T. Medical and Maintenance Treatments for Vitiligo. Dermatologic Clinics. 2017 04;35(2):163-170. https://doi.org/10.1016/j.det.2016.11.007

XV. Ezzedine K, Eleftheriadou V, Whitton M, van Geel N. Vitiligo. The Lancet. 2015 07;386(9988):74-84. https://doi.org/10.1016/s0140-6736(14)60763-7

XVI. Hönigsmann, H. and Schwarz, H. Ultraviolet light treatment, Physical treatment modalities. 2019; 2325-2341